Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection

Bing Xu, Fan Li, Wenjing Zhang, Yajuan Su, Ling Tang, Pengsheng Li, Jyotsna Joshi, Aaron Yang, Dong Li, Zhao Wang, Shu Wang, Jingwei Xie, Haiwei Gu, Wuqiang Zhu

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Acute myocardial infarction is a leading cause of death worldwide. We have previously identified two cardioprotective molecules — FGF1 and CHIR99021— that confer cardioprotection in mouse and pig models of acute myocardial infarction. Here, we aimed to determine if improved myocardial metabolism contributes to this cardioprotection. Nanofibers loaded with FGF1 and CHIR99021 were intramyocardially injected to ischemic myocardium of adult mice immediately following surgically induced myocardial infarction. Animals were euthanized 3 and 7 days later. Our data suggested that FGF1/CHIR99021 nanofibers enhanced the heart's capacity to utilize glycolysis as an energy source and reduced the accumulation of branched-chain amino acids in ischemic myocardium. The impact of FGF1/CHIR99021 on metabolism was more obvious in the first three days post myocardial infarction. Taken together, these findings suggest that FGF1/CHIR99021 protects the heart against ischemic injury via improving myocardial metabolism which may be exploited for treatment of acute myocardial infarction in humans.

Original languageEnglish (US)
Article number104447
Issue number6
StatePublished - Jun 17 2022


  • Health sciences
  • Nanotechnology
  • Omics

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection'. Together they form a unique fingerprint.

Cite this